Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$47K Sell
3,465
-2,490
-42% -$35.3K ﹤0.01% 667
2021
Q2
$86K Buy
+5,955
New +$86.2K ﹤0.01% 579

Other funds holding VTRS

BBVA USA's VTRS Position: Q3 2021 in Review

BBVA USA reduced its Viatris (VTRS) stake by 42% in Q3 2021, selling an estimated $35.3K and leaving 3,465 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

BBVA USA first reported a position in VTRS in Q2 2021 and has held it in 2 quarters since. The position peaked at $86K in Q2 2021. 1,016 funds tracked by Wall St. Rank hold VTRS as of Q3 2021.

  • BBVA USA held 3,465 shares of Viatris worth $47K as of Q3 2021.
  • BBVA USA sold 2,490 Viatris shares in Q3 2021, an estimated $35.3K.
  • Viatris made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #667 holding.
  • BBVA USA first reported a position in Viatris in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Viatris position peaked at $86K in Q2 2021.
  • 1,016 funds tracked by Wall St. Rank held Viatris as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.